Overall Survival (OS) of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) After Negative Invasive Mediastinal Staging

被引：0
|
作者：
Bourdages-Pageau, E. [1 ]
Vieira, A. [2 ]
Labbe, C. [2 ]
Figueroa, P. Ugalde [3 ]
机构：
[1] Laval Univ, Quebec City, PQ, Canada
[2] Iucpq, Thorac Surg, Quebec City, PQ, Canada
[3] Inst Univ Cardiol & Pneumol Quebec, Thorac Surg, Quebec City, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
mediastinal staging; pneumonectomy and lobectomy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-081
引用
收藏
页码：S2233 / S2234
页数：2
相关论文
共 50 条
  • [41] Joint modeling of overall survival (OS) and tumor size for patient-level predictions of survival in non-small cell lung cancer (NSCLC)
    Onishchenko, Dmitry
    Dunyak, James
    Masson, Eric
    Helmlinger, Gabriel
    Peskov, Kirill
    Tomkinson, Helen
    Stanski, Donald
    Al-Huniti, Nidal
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S138 - S138
  • [42] Overall survival (OS) implications of institutional disparities in non-small cell lung cancer (NSCLC) pathologic nodal (pN) staging practice in the National Cancer Data Base (NCDB)
    Osarogiagbon, Raymond U.
    Lin, Chun Chieh
    Smeltzer, Matthew
    Jemal, Ahmedin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Impact of induction chemotherapy prior to chemoradiotherapy on survival in patients with locally advanced non-small cell lung cancer (NSCLC)
    Ozkan, A.
    Kocak, M.
    Mayadagli, A.
    Parlak, C.
    Demir, O.
    Marti, A.
    Yilmaz, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S389 - S390
  • [44] Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC)
    Soussi, Ghassen
    Racil, Hajer
    Bacha, Saoussen
    Rouhou, Sana Cheikh
    Zidi, Asma
    Ayadi, Aida
    Chaouch, Nawel
    Chabbou, Abdellatif
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [45] Comorbidity and survival in advanced non-small cell lung cancer (NSCLC) veteran patients
    Chang, V. T.
    Hoover, D. R.
    Cogswell, J.
    Cholankeril, M.
    Badin, S.
    Yang, W.
    Yan, H.
    Gonzalez, M. L.
    Einhorn, J.
    Kasimis, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Associating Cardiac Plaque Accumulation With Cardiac Toxicity and Overall Survival In Locally Advanced Non-Small Cell Lung Cancer
    Haseltine, J.
    Apte, A.
    Jackson, A.
    Yorke, E.
    Yu, A.
    Wu, A.
    Peleg, A.
    Al-Sadawi, M.
    Iocolano, M.
    Gelblum, D.
    Shaverdian, N.
    Simone, C., II
    Rimner, A.
    Gomez, D.
    Shepherd, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1040 - S1041
  • [47] Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): Overall survival (OS) and updated safety from PROFILE 1001
    Shaw, A.
    Riely, G. J.
    Bang, Y-J.
    Kim, D-W.
    Camidge, D. R.
    Shapiro, G. I.
    Usari, T.
    Wang, S. C.
    Wilner, K.
    Clark, J. W.
    Ou, S-H. I.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Age is no barrier to radical chemoradiation in locally advanced non-small cell lung cancer (NSCLC)
    Gomberg, S.
    Hiley, C.
    Taylor, B.
    Ahmad, S.
    Smith, D.
    LUNG CANCER, 2019, 127 : S78 - S78
  • [49] Neoadjuvant treatment in the clinical practice of locally advanced non-small cell lung cancer (NSCLC).
    Arcuri, C
    Caffo, O
    Vanoni, V
    Silvestri, M
    Valduga, F
    Santarossa, S
    Galligioni, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 702S - 702S
  • [50] Impact of age on chemoradiation (CRT) for locally advanced non-small cell lung cancer (NSCLC)
    Dallas, J. L.
    Sullivan, J. E.
    Riggs, C. E.
    Hou, W.
    LaPlant, K. D.
    George, T. J.
    Louzon, P.
    Lynch, J. W.
    Close, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345